CAD 273,339.00
Reported federal agreement value. An agreement can cover several years; this is not the amount paid out.
Selected because the publisher reports recipient province NL; NL Ledger has not established the work, benefit or jurisdiction from this record; source fields are available below.
This is the whole reported commitment or notice value, not the amount paid or an NL allocation.
- Recipient
- Polyamyna Nanotech Inc.
- Public body
- National Research Council Canada
- Agreement start
- April 3, 2023
- Program
- Industrial Research Assistance Program – Contributions to Firms
- Record type
- Federal grant or contribution
Receipt
agreement 172-2023-2024-Q1-1006230, amendment 1
Source location evidence
Location review incomplete.
Reported address: country: CA; province: NL; city: St. John's|St. John's; postal code: A1E 6B5.
How counted: latest of 2 rows (department reports running totals). Start: 2023-04-03; end: 2025-06-30; reported: not stated. Amount: published value.
Full source fields
- _id
- 35930880
- ref_number
- 172-2023-2024-Q1-1006230
- amendment_number
- 1
- amendment_date
- 2025-01-14
- agreement_type
- C
- recipient_type
- F
- recipient_business_number
- 780785119
- recipient_legal_name
- Polyamyna Nanotech Inc.
- recipient_operating_name
- Polyamyna
- research_organization_name
- recipient_country
- CA
- recipient_province
- NL
- recipient_city
- St. John's|St. John's
- recipient_postal_code
- A1E 6B5
- federal_riding_name_en
- St. John's South--Mount Pearl
- federal_riding_name_fr
- St. John's-Sud--Mount Pearl
- federal_riding_number
- 10007
- prog_name_en
- Industrial Research Assistance Program – Contributions to Firms
- prog_name_fr
- Programme d’aide à la recherche industrielle – Contributions aux entreprises
- prog_purpose_en
- The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
- prog_purpose_fr
- Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
- agreement_title_en
- Clinical Research Trial of Keep Klear Transparent Microbicidal Coating Technology at Eastern Health Facility
- agreement_title_fr
- Essai de recherche clinique de la technologie de revêtement microbicide transparent Keep Klear dans un établissement de santé de l’est du pays
- agreement_number
- 1006230
- agreement_value
- 273339.0
- foreign_currency_type
- foreign_currency_value
- agreement_start_date
- 2023-04-03
- agreement_end_date
- 2025-06-30
- coverage
- IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
- description_en
- Keep Klear is the first technology of its kind to be approved for clinical research trials in Canada, which is set to take place with Eastern Health. The clinical research trial is divided into 3 phases, where this innovative microbicidal technology is subjected to diversified test conditions to understand (a) its integration (b) its effectiveness (c) its impact on patient outcomes/readmissions.
- description_fr
- Keep Klear est la première technologie de ce type à être approuvée pour des essais de recherche clinique au Canada, qui se dérouleront avec Eastern Health. L’essai de recherche clinique est divisé en trois phases au cours desquelles cette technologie microbicide innovante est soumise à diverses conditions d’essai pour comprendre (a) son intégration (b) son efficacité (c) son impact sur les résultats des patients/les réadmissions.
- naics_identifier
- 3255
- expected_results_en
- The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
- expected_results_fr
- Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
- additional_information_en
- This agreement has been amended 1 time(s). The end date of this agreements has been modified by 91 days. The total amended value is 73,339 dollars.
- additional_information_fr
- Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 91 jours. La valeur totale des modifications est de 73 339 dollars.
- owner_org
- nrc-cnrc
- owner_org_title
- National Research Council Canada | Conseil national de recherches Canada
Spot an error? Say so in the box below, or email corrections@nlledger.ca. What to send.